Skip to main content
Livermore
Livermore
US stocksTW
ZHEN

Karyopharm Therapeutics Inc.

KPTIQ
Industry
Pharmaceutical Preparations
SEC CIK
0001503802

In the last 90 days, Karyopharm Therapeutics Inc. insiders filed 0 open-market purchases and 3 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesKPTI

Four kinds of short-selling data, each measuring something different:

  • Short interest: shares sold short and not yet bought back, as of a settlement date. FINRA publishes it twice a month, about eight business days after the settlement date.
  • Daily short volume: shares sold short each day in off-exchange trades reported to FINRA. It counts trades, not open positions, and is published the next day.
  • Fails-to-deliver: shares not delivered by the settlement date. The SEC publishes them twice a month, about two weeks late.
  • ATS (dark pool) volume: weekly volume on alternative trading systems and other off-exchange venues. FINRA publishes it two to four weeks after the week.

More in the glossary.

No short-selling data

Livermore has no FINRA short interest, daily short volume or ATS volume, and no SEC fails-to-deliver, for KPTIQ. FINRA and the SEC report these for listed and OTC equities; some tickers, such as preferred shares, warrants or delisted stocks, have none.